Sunny Levine Comments on New SAMHSA Telehealth Proposal
January 10, 2023
Kaiser Health News
Foley & Lardner LLP Associate Sunny Levine is quoted in the Kaiser Health News article, “Behavioral Telehealth Loses Momentum Without a Regulatory Boost,” discussing the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) recent proposal to codify telehealth regulation on opioid treatment programs.
While this proposal only affects part of the sector and leaves unaddressed the process for individual providers to register to prescribe buprenorphine, Levine said the new rules “get us at least a little bit closer to where we need to go.”
This article also ran in CBS News.
Related News
April 3, 2026
In the News
David Rosen Weighs in on FDA's Pharma PR Crackdown – 'Stick to the Data'
Foley & Lardner LLP partner David Rosen shared insights on the regulatory challenges pharmaceutical companies face when publicly communicating around new cancer therapies in the MM+M article, “When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio.”
April 2, 2026
In the News
Susan Poll Klaessy and Adrienne Walker Named Chair and Vice Chair of Foley’s Bankruptcy & Business Reorganizations Practice
Foley & Lardner LLP partner Susan Poll Klaessy was appointed chair of the firm’s global Bankruptcy & Business Reorganizations Practice Group. Partner Adrienne Walker will serve as vice chair, supporting the continued growth and strategic direction of the practice.
April 1, 2026
In the News
Foley Featured on Top 10 Sales of 2025 List by Golf Inc.
Foley & Lardner LLP advised on two transactions named among Golf Inc.’s Top 10 Sales of 2025.